AAAAAA
Results:
1-12
|
Results: 12
Authors:
SVEDHEM V
LEBBAD M
STRUVE J
VERESS B
ANDSTROM E
AUSTKETTIS A
LINDER E
Citation: V. Svedhem et al., MICROSPORIDIA IN DUODENAL BIOPSIES FROM 72 HIV-INFECTED PATIENTS WITHABDOMINAL COMPLAINTS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 106(5), 1998, pp. 535-538
Authors:
LORENZEN K
STRUVE J
COWAN VJ
Citation: K. Lorenzen et al., IMPACT OF FARMING INTENSITY AND WATER MANAGEMENT ON NITROGEN DYNAMICSIN INTENSIVE POND CULTURE - A MATHEMATICAL-MODEL APPLIED TO THAI COMMERCIAL SHRIMP FARMS, Aquaculture research, 28(7), 1997, pp. 493-507
Authors:
KROOK A
ALBERT J
ANDERSSON S
BIBERFELD G
BLOMBERG J
EKLUND I
ENGSTROM A
JULANDER I
KALL K
MARTIN C
STENDAHL P
STRUVE J
SONNERBORG A
Citation: A. Krook et al., PREVALENCE AND RISK-FACTORS FOR HTLV-II INFECTION IN 913 INJECTING DRUG-USERS IN STOCKHOLM, 1994, Journal of acquired immune deficiency syndromes and human retrovirology, 15(5), 1997, pp. 381-386
Authors:
CARLSSON T
STRUVE J
Citation: T. Carlsson et J. Struve, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GIVEN AS AN ADJUVANTTO PERSONS NOT RESPONDING TO HEPATITIS-B VACCINE, Infection, 25(2), 1997, pp. 129-129
Authors:
STRUVE J
GIESECKE J
LINDH G
WEILAND O
Citation: J. Struve et al., UTILITY OF AN ANONYMOUS QUESTIONNAIRE FOR THE IDENTIFICATION OF A PRIMARY TRANSMISSION ROUTE AND POSSIBLE SECONDARY TRANSMISSION IN ADULTS WITH ACUTE HEPATITIS-B VIRUS-INFECTION, European journal of epidemiology, 12(3), 1996, pp. 319-322
Authors:
KROOK A
ALBERT J
ANDERSSON S
ENGSTRAND A
JULANDER I
KALL K
STENDAHL P
STRUVE J
SONNERBORG A
Citation: A. Krook et al., HUMAN T-LYMPHOTROPIC VIRUS TYPE-II AMONG INJECTING DRUG-USERS IN STOCKHOLM 1994, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 267-267
Authors:
STRUVE J
ARONSSON B
FRENNING B
FORSGREN M
WEILAND O
Citation: J. Struve et al., RESPONSE TO A BOOSTER DOSE 18 MONTHS AFTER A LOW ANTI-HBS RESPONSE (10-99 IU I) TO 3 DOSES OF INTRADERMALLY OR INTRAMUSCULARLY ADMINISTEREDRECOMBINANT HEPATITIS-B VACCINE/, Infection, 23(1), 1995, pp. 42-45
Authors:
STRUVE J
NORRBOHM O
STENBECK J
GIESECKE J
WEILAND O
Citation: J. Struve et al., RISK-FACTORS FOR HEPATITIS-A, HEPATITIS-B AND HEPATITIS-C VIRUS-INFECTION AMONG SWEDISH EXPATRIATES, The Journal of infection, 31(3), 1995, pp. 205-209
Authors:
STRUVE J
BENNET R
EHRNST A
ERIKSSON M
HEDLUND KO
HERIN P
SAMUELSSON A
Citation: J. Struve et al., NOSOCOMIAL CALICIVIRUS GASTROENTERITIS IN A PEDIATRIC HOSPITAL, The Pediatric infectious disease journal, 13(10), 1994, pp. 882-885
Authors:
STRUVE J
ARONSSON B
FRENNING B
FORSGREN M
WEILAND O
Citation: J. Struve et al., SEROCONVERSION AFTER ADDITIONAL VACCINE DOSES TO NONRESPONDERS TO 3 DOSES OF INTRADERMALLY OR INTRAMUSCULARLY ADMINISTERED RECOMBINANT HEPATITIS-B VACCINE, Scandinavian journal of infectious diseases, 26(4), 1994, pp. 468-470
Authors:
STRUVE J
ARONSSON B
FRENNING B
FORSGREN M
WEILAND O
Citation: J. Struve et al., PREVALENCE OF ANTIBODIES AGAINST HEPATITIS-C VIRUS-INFECTION AMONG HEALTH-CARE WORKERS IN STOCKHOLM, Scandinavian journal of gastroenterology, 29(4), 1994, pp. 360-362
Authors:
STRUVE J
GIESECKE J
Citation: J. Struve et J. Giesecke, COST OF ACUTE HEPATITIS-B INFECTION IN SWEDISH ADULTS, Scandinavian journal of infectious diseases, 25(6), 1993, pp. 693-697
Risultati:
1-12
|